Procedure: Fluoroscopic guided injection of the left acromioclavicular
joint, 4/5/2011.
Contrast: 0.1 cc of Omnipaque 300.
Clinical History: AC joint derangement.
Written informed consent was obtained prior to the procedure. A 25-gauge
needle was advanced tothe left acromioclavicular joint utilizing local anesthesia, sterile
technique andfluoroscopic guidance. A small amount of iodinated contrast was injected to
confirm the needleplacement. Subsequently, 0.25 cc of 0.25% preservative free bupivacaine and 0.25cc (10mg) ofKenalog steroid were injected. There were no immediate complications.
The patient's preprocedural pain level was 5 /10, and immediately
postprocedure it was 5 /10.
Total fluoroscopy time was 19 seconds.
Impression: Injection of the left acromioclavicular joint under fluoroscopic guidance,
without complication.
joint, 4/5/2011.
Contrast: 0.1 cc of Omnipaque 300.
Clinical History: AC joint derangement.
Written informed consent was obtained prior to the procedure. A 25-gauge
needle was advanced tothe left acromioclavicular joint utilizing local anesthesia, sterile
technique andfluoroscopic guidance. A small amount of iodinated contrast was injected to
confirm the needleplacement. Subsequently, 0.25 cc of 0.25% preservative free bupivacaine and 0.25cc (10mg) ofKenalog steroid were injected. There were no immediate complications.
The patient's preprocedural pain level was 5 /10, and immediately
postprocedure it was 5 /10.
Total fluoroscopy time was 19 seconds.
Impression: Injection of the left acromioclavicular joint under fluoroscopic guidance,
without complication.
